Apeloa Pharmaceutical Co

Apeloa Pharmaceutical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apeloa Pharmaceutical Co (000739.SZ) as of Oct 11, 2026 is 878.92 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.37 B CNY — a change of -35.83% (lower).

EBITDA

878.92 MCNY

YoY

-35.83%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apeloa Pharmaceutical Co is 2025 878.92 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apeloa Pharmaceutical Co was 2024 1.37 B CNY. It decreases by -35.83% lower compared to the previous year.

The Apeloa Pharmaceutical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
583.83 M CNY
Jan 1, 2019
747.35 M CNY
Jan 1, 2020
1.07 B CNY
Jan 1, 2021
1.25 B CNY
Jan 1, 2022
1.16 B CNY
Jan 1, 2023
1.38 B CNY
Jan 1, 2024
1.37 B CNY
Jan 1, 2025
878.92 M CNY
The Apeloa Pharmaceutical Co EBITDA history
YEAREBITDAYoY
878.92 MCNY-35.83%
1.37 BCNY-0.55%
1.38 BCNY+19.01%
1.16 BCNY-7.42%
1.25 BCNY+16.57%
1.07 BCNY+43.48%
747.35 MCNY+28.01%
583.83 MCNY+33.46%
437.45 MCNY+24.18%
352.26 MCNY+23.97%
284.14 MCNY-32.58%
421.47 MCNY—
Access this data via the Eulerpool API
Get Free API Key

Apeloa Pharmaceutical Co Stock analysis

What does Apeloa Pharmaceutical Co do? Apeloa Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apeloa Pharmaceutical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apeloa Pharmaceutical Co is 878.92 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apeloa Pharmaceutical Co changed from 1.37 B CNY to 878.92 M CNY, representing a -35.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Apeloa Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Apeloa Pharmaceutical Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Apeloa Pharmaceutical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Apeloa Pharmaceutical Co